New therapeutic treatments that employ biological drugs are gradually more used in chronic, degenerative, progressive and oncological diseases. The personalized therapy is mandatory in an increasing number of patients, and thus the beneficial or adverse effects, as well as the evolution of the disease in each single patient, have to be evaluated and monitored by efficacious laboratory analytical procedures. This review is focused on an efficient approach and outcome of EBLM in this new promising field.